AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PRO MEDICUS LTD

205.330

-1.840-0.89%

Volume:194.90K

Turnover:40.02M

Market Cap:21.45B

PE:218.57

High:206.940

Open:203.350

Low:201.510

Close:207.170

Loading ...

Overview Company News Filings

ASX Market Close: Reject Shop rockets ~ 110% after Canadian offer | March 27, 2025

The Market Herald

Pro Medicus shares drop 7%: falling knife or buying opportunity?

Why Domain, Mesoblast, Pro Medicus, and Tuas shares are tumbling today

Pro Medicus Looks Fairly Valued Post Sell-off -- Market Talk

Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Near-Term Growth Forecasts

Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Down Near-Term Growth Forecasts

BUZZ-Jefferies adjusts down Australia's Pro Medicus' near-term growth forecasts

Top brokers name 3 ASX shares to buy today

Pro Medicus shares up 255% in 2 years! Will the bubble burst?

Morgans Financial Upgrades Pro Medicus to Add from Hold; Price Target is AU$250

MT Newswires Live

Exploring Audinate Group And 2 Emerging Australian High Growth Tech Stocks

Simply Wall St.

Australian shares edge up as supermarkets rally

Stock Track | Pro Medicus Plummets 5% Despite Analyst Optimism on Long-Term Prospects

9 ASX stocks the pros have been eyeing amid the market pullback

Here's how I think about owning gold, bitcoin, and stocks in Trump's world

Winning by not losing: The silver rule of investing

Morning Star AU

How to navigate the Trump Slump?

49% of Pro Medicus Limited (ASX:PME) is owned by insiders, and they've been buying recently

Simply Wall St.

Pro Medicus shares are down 20%. Is this a buying opportunity?

3 excellent ASX 200 growth shares to buy and hold with $3,000

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PME.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PME.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","market":"AU","secType":"STK","nameCN":"PRO MEDICUS LTD","latestPrice":205.33,"timestamp":1745302320000,"preClose":207.17,"halted":0,"volume":194895,"delay":0,"nameEN":"PRO MEDICUS LTD","floatShares":52960584,"shares":104462909,"eps":0.939404,"marketStatus":"Not Yet Opened","change":-1.84,"latestTime":"04-22 16:12:00 AEST","open":203.35,"high":206.94,"low":201.51,"amount":40021191,"amplitude":0.02621,"askPrice":205.84,"askSize":250,"bidPrice":203.5,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.939404,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":207.17,"dividendRate":0.002289,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":0.9073754904045027,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","floatShares":52960584,"roa":"32.90%","roe":"51.53%","lyrEps":0.792737,"volumeRatio":0.9073754904045027,"shares":104462909,"dividePrice":0.47,"high":206.94,"amplitude":0.02621,"preClose":207.17,"low":201.51,"week52Low":106.728,"pbRate":"96.51","psRate":"116.21","week52High":298.706,"institutionHeld":0,"latestPrice":205.33,"committee":-0.960784,"eps":0.939404,"divideRate":0.002289,"volume":194895,"delay":0,"ttmEps":0.939404,"open":203.35,"prevYearClose":249.891,"prevWeekClose":207.17,"prevMonthClose":199.79,"prevQuarterClose":199.79,"fiveDayClose":202.6,"twentyDayClose":223.58,"sixtyDayClose":269.993},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PME.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522319667","title":"ASX Market Close: Reject Shop rockets ~ 110% after Canadian offer | March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522319667","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522319667?lang=en_us&edition=fundamental","pubTime":"2025-03-27 13:54","pubTimestamp":1743054840,"startTime":"0","endTime":"0","summary":"The ASX200 closed down 0.38% at 7,969 points.Energy was the best performing sector, up1%, followed by Staples, up 0.4%, and Materials, up 0.33%.Real Estate was the biggest loser, down 2.2%, followed, IT, down 2%, and Discretionary, down 1%.Core Lithium  closed up 5.2% following the release of anupdateon its Finniss Lithium Operation.Neuren Pharmaceuticals  finished up 0.67% on news the company is developing a new product to treat infant injuries when a baby’s brain does not receive enough oxygen or blood flow before or shortly after birth.And, Reject Shop  has closed up 109% after investors flocked to the stock as the company received a takeover offer. Canada’s Dollarama  cut a deal to buy Reject Shop for $259 million.Domain  closed down 4.9% after CoStar Group  improved its takeover offer, from $4.20 cash per share to $4.43 per share.And, WiseTech  closed down 2% as investors reacted to Australian Super selling its entire $580M stake in the company. AusSuper’s move came due to “govern","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-reject-shop-rockets-110-after-canadian-offer-march-27-2025-2025-03-27/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["IE0009356076.USD","BK4585","BK4123","LU0708995401.HKD","LU0390134368.USD","BK7096","BK7504","BK7095","BK7016","BK4588","CXO.AU","BK7094","BK4079","BK7041","BK7503","BK4548","CSGP","LU0109391861.USD","LU0672654240.SGD","LU2210150020.SGD","LU2095319765.USD","IE0004445239.USD","BK7002","BK7153","PME.AU","LU2210149790.SGD","BK7508","WTC.AU","DHG.AU","LU0320765059.SGD","LU1267930730.SGD","NEU.AU","TRS.AU"],"gpt_icon":0},{"id":"2522349132","title":"Pro Medicus shares drop 7%: falling knife or buying opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522349132","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522349132?lang=en_us&edition=fundamental","pubTime":"2025-03-27 13:28","pubTimestamp":1743053300,"startTime":"0","endTime":"0","summary":"No-one has a crystal ball to tell what's going to happen next. Shares go up and down in price every week. There can be quite dramatic swings in a relatively short amount of time, if they react to business updates or wider economic issues. Investors seem worried about what's going on with the US' tariffs  and how that could have negative flow-on effects. Various ASX growth shares have seen declines in recent weeks. One of the main  criticisms, in my opinion, that could be said about Pro Medicus shares is that it trades on a high price/earnings (P/E) ratio. For example, even after the decline, the Pro Medicus share price is trading at 198x FY25's estimated earnings, according to Commsec. Is it a buying opportunity?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/27/pro-medicus-shares-drop-7-falling-knife-or-buying-opportunity/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4185","PME.AU","PACS","BK7094","EBIT"],"gpt_icon":0},{"id":"2522391277","title":"Why Domain, Mesoblast, Pro Medicus, and Tuas shares are tumbling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2522391277","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522391277?lang=en_us&edition=fundamental","pubTime":"2025-03-27 10:56","pubTimestamp":1743044164,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is having a poor session on Thursday. In afternoon trade, the benchmark index is down 0.5% to 7,960.9 points. Four ASX shares that are falling more than most today are ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/27/why-domain-mesoblast-pro-medicus-and-tuas-shares-are-tumbling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0672654240.SGD","BK7042","BK4139","BK7002","BK7067","BK4588","LU2095319765.USD","TUA.AU","DHG.AU","IE0009356076.USD","MESO","BK7501","BK4548","CSGP","LU2210149790.SGD","LU0320765059.SGD","BK4585","PME.AU","LU0109391861.USD","BK7503","LU0390134368.USD","BK7094","LU2210150020.SGD","BK4575","BK4079","BK4123","MSC","IE0004445239.USD","BK7508","XJO.AU","MSB.AU","BK4150","LU1267930730.SGD","LU0708995401.HKD"],"gpt_icon":0},{"id":"2522393280","title":"Pro Medicus Looks Fairly Valued Post Sell-off -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2522393280","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522393280?lang=en_us&edition=fundamental","pubTime":"2025-03-27 10:24","pubTimestamp":1743042240,"startTime":"0","endTime":"0","summary":"0224 GMT - Medical-imaging tech-provider Pro Medicus needs to improve the visibility of its business pipeline or demonstrate an ability to speed up market-share gains in order to turn Macquarie analysts more positive on the stock. The analysts moderate their market-share assumption to 10% in fiscal 2027, from 11% previously. They say to clients in a note that they have largely factored in the announcement of further contract wins and renewals. Pro Medicus has yet to demonstrate material uptake of opportunities in adjacent specialities, such as cardiology, they say, adding that they see the stock as fairly valued following a recent de-rate. Macquarie trims its target price by 0.4% to A$257.40, maintaining a neutral rating. Shares are down 7.6% at A$210.405. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","BK7094","BK4212","POST"],"gpt_icon":0},{"id":"1165001079","title":"Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Near-Term Growth Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1165001079","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165001079?lang=en_us&edition=fundamental","pubTime":"2025-03-27 07:36","pubTimestamp":1743032178,"startTime":"0","endTime":"0","summary":"Shares of Pro Medicus Ltd , an Australian health imaging firm, plummeted 5.02% in Thursday's intraday trading session following Jefferies' downward revision of the company's near-term growth forecasts. The adjustment comes as a result of reassessing the impact of the Trinity contract and cardiology contribution estimates.Jefferies has trimmed Pro Medicus' cardiology contribution estimates, leading to a reduced implied market share increase projection. The brokerage now forecasts a 14% market sha","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PME.AU"],"gpt_icon":0},{"id":"1143291145","title":"Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Down Near-Term Growth Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1143291145","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143291145?lang=en_us&edition=fundamental","pubTime":"2025-03-27 07:36","pubTimestamp":1743032177,"startTime":"0","endTime":"0","summary":"Shares of Pro Medicus Ltd , an Australian health imaging firm, plummeted 5.02% in Thursday's trading session following a report from Jefferies that revised down the company's near-term growth forecasts.The brokerage firm cited the stepped minimum nature of the Trinity contract as a key factor in their decision to adjust Pro Medicus' growth projections. Jefferies also trimmed its estimates for the company's cardiology contribution, resulting in a reduction of the implied market share increase to ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Down Near-Term Growth Forecasts","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PME.AU"],"gpt_icon":0},{"id":"2522302073","title":"BUZZ-Jefferies adjusts down Australia's Pro Medicus' near-term growth forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522302073","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522302073?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:12","pubTimestamp":1743019950,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies adjusts down Australia's Pro Medicus' near-term growth forecasts** Jefferies revises down health imaging firm Pro Medicus' PME.AX near-term growth forecasts, considering the stepped minimum nature of the Trinity contract** Brokerage trims firm's cardiology contribution estimates, leading to implied market share increase to 14% in FY26, down 15% from previous estimates** Despite these adjustments, brokerage maintains its A$250 price target and 'Hold' rating** Stock down 9% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3N3Q91JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2522825871","title":"Top brokers name 3 ASX shares to buy today","url":"https://stock-news.laohu8.com/highlight/detail?id=2522825871","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522825871?lang=en_us&edition=fundamental","pubTime":"2025-03-26 09:20","pubTimestamp":1742952040,"startTime":"0","endTime":"0","summary":"Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week. Three ASX shares that brok","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/26/top-brokers-name-3-asx-shares-to-buy-today-26-march-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7506","BK7104","BK7119","BK7094","PME.AU","BRG.AU","GOR.AU"],"gpt_icon":0},{"id":"2522327248","title":"Pro Medicus shares up 255% in 2 years! Will the bubble burst?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522327248","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522327248?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:29","pubTimestamp":1742938182,"startTime":"0","endTime":"0","summary":"Pro Medicus Ltd  is an Australian healthcare technology company. It develops and sells radiology imaging software used in hospitals and medical imaging centres. Over the last two years Pro Medicus shares have grown by a massive 255%.  On one hand you might look at this growth and think you're too late to the party and have missed an opportunity. On the other hand, quality holdings can continue to hit record high after record high and a one or two year run could be just the beginning. Let's look at both sides of the coin. Can Pro Medicus continue to soar?Of course buying shares in a company that has skyrocketed over the last two years like Pro Medicus can be daunting. It's possible the future growth that many have predicted is already baked into its current share price, and investors have overvalued this tech stock. Its lofty price to earnings ratio of 238 could also be a red flag for some. Another option for investors who are looking to dip their toe in the water could be an ETF like B","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/26/pro-medicus-shares-up-255-in-2-years-will-the-bubble-burst/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","PME.AU","ATEC.AU"],"gpt_icon":0},{"id":"2522012812","title":"Morgans Financial Upgrades Pro Medicus to Add from Hold; Price Target is AU$250","url":"https://stock-news.laohu8.com/highlight/detail?id=2522012812","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522012812?lang=en_us&edition=fundamental","pubTime":"2025-03-25 17:24","pubTimestamp":1742894678,"startTime":"0","endTime":"0","summary":"Pro Medicus (ASX:PME) has an average rating of hold and mean price target of AU$272.31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PME.AU"],"gpt_icon":0},{"id":"2522704765","title":"Exploring Audinate Group And 2 Emerging Australian High Growth Tech Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2522704765","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522704765?lang=en_us&edition=fundamental","pubTime":"2025-03-25 03:05","pubTimestamp":1742843149,"startTime":"0","endTime":"0","summary":"The Australian market recently saw the ASX200 close flat at 7,936 points with mixed performance across sectors, as Discretionary and Financials led gains while Information Technology lagged behind. In this environment of fluctuating sector performance, identifying high growth tech stocks like Audinate Group and other emerging players in Australia involves looking for companies that demonstrate resilience and innovation amidst broader market challenges.Operations: The company generates revenue primarily through its Value-Added IT Reseller and IT Solutions Provider segment, which accounts for A$798.05 million. The business focuses on delivering comprehensive IT solutions and services across multiple regions, contributing to its","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-audinate-group-2-emerging-190549564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XAO.AU","AD8.AU","BK7094","XKO.AU","PME.AU","BK7503","DTL.AU","BK7061","XJO.AU","BK7073"],"gpt_icon":0},{"id":"2521425052","title":"Australian shares edge up as supermarkets rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2521425052","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521425052?lang=en_us&edition=fundamental","pubTime":"2025-03-21 14:23","pubTimestamp":1742538185,"startTime":"0","endTime":"0","summary":"Australian shares edge up as supermarkets rallyASX200 benchmark logs best week this yearWoolworths and Coles jump about 6% and 5%, respectivelyStaples stocks clock best daily gain in nearly 5 yearsHea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL4N3Q40CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7094","BK7040","PME.AU","BK7511","CSL.AU","BK7135","BK7501","BK7508","CBA.AU","WOW.AU"],"gpt_icon":0},{"id":"1145521209","title":"Stock Track | Pro Medicus Plummets 5% Despite Analyst Optimism on Long-Term Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1145521209","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145521209?lang=en_us&edition=fundamental","pubTime":"2025-03-21 10:52","pubTimestamp":1742525553,"startTime":"0","endTime":"0","summary":"Shares of Pro Medicus  plummeted 5.01% in Friday's trading session, extending recent losses for the health imaging technology company. The sharp decline comes despite some analysts remaining bullish on the stock's long-term growth potential.Pro Medicus, which provides radiology information systems and imaging software, has seen its stock price pull back significantly in recent weeks. Prior to Friday's drop, the shares had already fallen approximately 20% from their recent highs, according to com","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PME.AU"],"gpt_icon":0},{"id":"2521417865","title":"9 ASX stocks the pros have been eyeing amid the market pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2521417865","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521417865?lang=en_us&edition=fundamental","pubTime":"2025-03-21 10:39","pubTimestamp":1742524752,"startTime":"0","endTime":"0","summary":"The recent market pullback has sparked debate among investors — is it a golden buying opportunity or a time for caution?I asked three popular Livewire contributors to get their perspectives on market conditions, their portfolio strategies, and to share their top stock picks at this time.Filapek-Vandyck takes a cautious stance, noting that while markets have corrected, the economic environment is shifting. Uncertainty around U.S. policy, tariffs, and consumer sentiment means that not all declining stocks represent value.“Everything that has come down is not necessarily ‘great value’.  In other words, they might come down further....a diversified portfolio with a mix of growth, value, and defensive holdings is key to managing risk in volatile markets.”TechnologyOne posted strong results, marking its 15th year of record growth. Profit rose 18%, and recurring revenue grew 20%, driven by its SaaS+ platform and UK expansion. As Australia's top ERP SaaS provider, it continues to strengthen it","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/9-asx-stocks-the-pros-have-been-eyeing-amid-the-market-pullback","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/9-asx-stocks-the-pros-have-been-eyeing-amid-the-market-pullback","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7094","BK7503","BK7078","DDR.AU","WAF.AU","XKO.AU","BK7104","BK7050","BK7016","BK7099","IPH.AU","TNE.AU","BK7510","XRO.AU","XAO.AU","BK7068","LNW.AU","GMG.AU","BK7506","XJO.AU","PME.AU","BK7155"],"gpt_icon":0},{"id":"2521448933","title":"Here's how I think about owning gold, bitcoin, and stocks in Trump's world","url":"https://stock-news.laohu8.com/highlight/detail?id=2521448933","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521448933?lang=en_us&edition=fundamental","pubTime":"2025-03-21 10:36","pubTimestamp":1742524580,"startTime":"0","endTime":"0","summary":"As an investor it's important to adapt and US President Trump's tendency to fuel geopolitical chaos is now being transmitted through markets via a stunning gold price rise to a record high above $3050 this week.The surge means the Australian dollar has now lost half its purchasing power versus gold in just three years in a historic once-in-a-lifetime move that's pushed an ounce of gold in the local currency to $4840 today, versus $2280 just thee years ago.These kind of rapid collapses in major fiat currencies are not normal and something people aiming to preserve and create wealth for their family should pay attention to. So let's consider what's going on.Gold is traditionally promoted as a hedge against inflation, but until 2022 its steady price appreciation trailed other asset classes such as good quality residential property in Australia as an inflation hedge.What's really sent gold soaring since February 2022 is worsening geopolitical splits globally.Of course over the long-term th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/here-s-how-i-think-about-owning-gold-bitcoin-and-stocks-in-trump-s-world","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/here-s-how-i-think-about-owning-gold-bitcoin-and-stocks-in-trump-s-world","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["PME.AU","BK4213","XKO.AU","XJO.AU","BK7094","XAO.AU","GDP"],"gpt_icon":0},{"id":"2520450698","title":"Winning by not losing: The silver rule of investing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520450698","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520450698?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:00","pubTimestamp":1742400000,"startTime":"0","endTime":"0","summary":"ask, “How can I avoid the worst ones?”This mindset shift is at the heart of the Silver Rule. By focusing on what not to do, you create a framework for consistent, long-term success.For Terry Smith, rather than obsessing over","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/insights/personal-finance/Y6YFBDTDORG3ZOH4REYQPKF4DM/winning-by-not-losing-the-silver-rule-of-investing","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["LU0528227936.USD","LU0672654240.SGD","3NVD.UK","BK4567","LU1923623000.USD","LU0348723411.USD","NVD","LU1429558221.USD","LU2294711713.HKD","LU2552382132.HKD","IE00BDCRKT87.USD","LU2242649171.HKD","LU2290526834.HKD","LU2413666699.HKD","LU0056508442.USD","NVD2.UK","LU2168564495.EUR","NVDS.UK","NVIW.SI","LU0640476718.USD","LU1571399168.USD","LU2191332357.HKD","IE00B775H168.HKD","LU1244550221.USD","LU0345770993.USD","LU0345768740.USD","SNVD.UK","LU0107464264.USD","NVDS","NVD3.UK","2NVD.UK","PME.AU","LU2756315664.SGD","LU2250418816.HKD","IE00BQXX3C00.GBP","IE00B3M56506.USD","NVDD","IE00B19Z8X17.USD","LU0466842654.USD","LU0096364046.USD","SG9999015952.SGD","LU2125909247.SGD","IE00BZ199S13.USD","LU0077335932.USD","NVDY","LU2125909759.SGD","NVDU"],"gpt_icon":1},{"id":"2520193869","title":"How to navigate the Trump Slump?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520193869","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520193869?lang=en_us&edition=fundamental","pubTime":"2025-03-19 12:06","pubTimestamp":1742357215,"startTime":"0","endTime":"0","summary":"Financial markets are now, broadly measured, divided into two categories of people, as is in fact the global population, including those who do not actively invest:. -those who look at events unfolding from the perspective that nothing fundamentally has changed, waiting for 'old' dynamics to re-assert themselves in due course. -those who instinctively, or otherwise, sense things are changing, but there are no answers yet available as to what exactly the end outcome might be. The division between these two groups of people is nothing new. This happens every time financial markets change direction and composure. It's human nature to stick to the familiar script and view the world through an unchanged lens long after the facts have fundamentally changed.One mistake investors on Wall Street, and elsewhere, have made is to solely concentrate on the pro-business policies this freshly installed Trump 2.0 administration embodies. Less red tape and lower taxes equals higher share prices, right?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/how-to-navigate-the-trump-slump","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/how-to-navigate-the-trump-slump","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["SGH.AU","BSL","TNE.AU","ETF.AU","BSL.AU","WES","IEL.AU","BK7040","XRO.AU","CAR.AU","RMD","WOW","CAR","BK4180","BK4567","NWL.AU","ALL.AU","BK7046","BK7503","BK7001","BK7082","BK7511","JBH.AU","LU2177674079.SGD","GMG.AU","BK7041","GPT.AU","BK7016","NWL","ALL","BK7031","BK7087","BK4022","WES.AU","BK4585","PME.AU","COL.AU","CHC.AU","BK4548","BK4588","LU1571399168.USD","BK4590","BK7153","HUB.AU","RMD.AU","MQG.AU","WOW.AU","PME","BK7062","BK7129"],"gpt_icon":0},{"id":"2520915366","title":"49% of Pro Medicus Limited (ASX:PME) is owned by insiders, and they've been buying recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2520915366","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520915366?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:12","pubTimestamp":1742328779,"startTime":"0","endTime":"0","summary":"Key Insights Insiders appear to have a vested interest in Pro Medicus' growth, as seen by their sizeable ownership 51...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/49-of-pro-medicus-limited-asxpme-is-owned-by-insiders-and-th","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PME","BK4212","BK7094","PME.AU"],"gpt_icon":0},{"id":"2520443652","title":"Pro Medicus shares are down 20%. Is this a buying opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520443652","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520443652?lang=en_us&edition=fundamental","pubTime":"2025-03-18 06:23","pubTimestamp":1742250222,"startTime":"0","endTime":"0","summary":"The Pro Medicus Ltd (ASX: PME) share price has fallen just over 20% from its recent peak on 19 February 2025, as the chart below shows. Plenty of ASX growth shares have also suffered double-digit decl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/18/pro-medicus-shares-are-down-20-is-this-a-buying-opportunity/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["EBIT","BK7094","PME.AU"],"gpt_icon":0},{"id":"2520934681","title":"3 excellent ASX 200 growth shares to buy and hold with $3,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2520934681","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520934681?lang=en_us&edition=fundamental","pubTime":"2025-03-18 05:29","pubTimestamp":1742246980,"startTime":"0","endTime":"0","summary":"For investors looking to put $3,000 to work in the share market, ASX 200 growth shares can be a great way to build long-term wealth.Right now, three ASX 200 growth shares stand out as great long-term buys according to analysts. Here's why they could be worth adding to your portfolio.The first ASX 200 growth share to look at is Aristocrat Leisure. It is one of the world's largest gaming technology companies, developing and supplying slot machines, digital gaming platforms, and social casino apps.The company has built a dominant position in the land-based gaming industry while also aggressively expanding into digital gaming through its mobile and online offerings.The company's mobile gaming division, Pixel United, has been another driver of growth in recent years, helping diversify revenue beyond traditional slot machines. In addition, Aristocrat has moved into real-money online gaming, which presents another long-term opportunity.What makes Pro Medicus particularly exciting is its abili","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/18/3-excellent-asx-200-growth-shares-to-buy-and-hold-with-3000/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7016","BK4023","LIF","BK7094","BK4613","360.AU","ALL.AU","BK7078","PME.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PME.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-27","symbol":"PME.AU","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-28","name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-02-28","currency":"AUD","dateTimestamp":1740574800000,"payDate":"2025-03-21"},{"date":"2025-02-11","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-04","symbol":"PME.AU","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-05","defaultRemindTime":1725408000000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-26","payableDate":"2024-09-05","currency":"AUD","dateTimestamp":1725372000000,"payDate":"2024-09-26"},{"date":"2024-08-14","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723593600000,"name":null,"time":"","dateTimestamp":1723557600000,"actualEps":null},{"date":"2024-02-29","symbol":"PME.AU","amount":0.18,"announcedDate":null,"type":"dividend","market":"AU","newRecordDate":"2024-03-01","defaultRemindTime":1709161200000,"name":"Pro Medicus Ltd","recordDate":"2024-03-22","payableDate":"2024-03-01","currency":"AUD","dateTimestamp":1709125200000,"payDate":"2024-03-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PME.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-02","value":0.06,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-19","value":0.07,"currency":"AUD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-10-01","value":0.08,"currency":"AUD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-25","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.12,"currency":"AUD"}]}}